Corrigendum
Laboratory Investigation (2008) 88, 450; doi:10.1038/labinvest.2008.9
Nuclear E-cadherin and VHL immunoreactivity are prognostic indicators of clear-cell renal cell carcinoma
Michelle L Gervais, Pauline C Henry, Arthy Saravanan, T Nadine Burry, Brenda L Gallie, Michael A S Jewett, Richard P Hill, Andrew J Evans and Michael Ohh
Top of page
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Bortezomib: efficacy comparisons in solid tumors and hematologic malignancies
Nature Clinical Practice Oncology Review (01 Jul 2006)
NEWS AND VIEWS
Ankyrin for clues about the function 0fp16 INK4a
Nature Structural Biology News and Views (01 Feb 1998)
